LewisGale Medical Center will be first to use robotic bronchoscope in Virginia

Roanoke Valley News

SALEM, Va. (WFXR) — A new robotic technology will help lung cancer patients in the Commonwealth. The MONARCH robotic Bronchoscope will be the first tech to be used at LewisGale Medical Center (LGMC) to help treat lung cancer patients.

MONARCH Robotic Bronchoscope at LewisGale Medical Center

“Lung cancer is the leading cause of cancer deaths worldwide, in part because it has no symptoms in its early
stages,” said Dr. Nelson Greene, board-certified specialist in pulmonary diseases and critical care medicine. with LGMC. “Because this innovative, robotic bronchoscope provides improved reach, vision, and control for
bronchoscopic procedures, it holds potential to help us diagnose lung cancer in an early stage when it can be treated more effectively. We are excited about the promise of this technology to offer better outcomes for our patients with lung cancer.”

This robotic technology helps doctors detect hard-to-reach, potentially cancerous lung nodules earlier. It can reach anywhere in the lungs including the periphery, or the outer part of the lung, where these nodules can develop. This helps doctors treat patients more effectively because it can detect lung cancer at an earlier stage.

“This new technology is another significant step in the development of our comprehensive Lung Cancer
Program. It further strengthens innovative practices that we already have in place, including analyzing CT exams and improve outcomes for patients at risk for future disease,” said Dr. Harsukh Patolia, chief of staff with LGMC. “For patients diagnosed with lung cancer, robotic-assisted surgery is performed when possible for faster recovery, and our full-service cancer centers offer the latest chemotherapy, radiation, and targeted therapy treatments.”

MONARCH Robotic Bronchoscope at LewisGale Medical Center

The American Lung Association reported that the lung cancer survival rate is lower than many other leading cancer sites. A five-year survival rate is 18.6 percent lower because only 16 percent of lung cancer cases are diagnosed at an early stage. There are several diagnostic options available but they have limitations in accuracy, safety, or invasiveness, which results in higher healthcare costs and longer hospital stays.

“We are very pleased to bring this unique system to southwest Virginia, and especially to our community, where lung cancer incidence rates are among the highest in the Commonwealth,” said Lance Jones, market president of LewisGale Health System. “This new technology is just one of the many benefits our partnership with Sarah Cannon Cancer Institute will bring to physicians and patients in this region.”

Get breaking news, weather, and sports delivered to your smartphone with the WFXR News app available on Apple and Android.

For breaking news delivered to you, subscribe to WFXR’s breaking news email list

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest News

More News

News Tip Form